Journal of Molecular and Cellular Cardiology
Volume 48, Issue 5 , Pages 910-916 , May 2010

Insulin signaling regulates cardiac titin properties in heart development and diabetic cardiomyopathy

  • Martina Krüger

      Affiliations

    • Dept. of Cardiovascular Physiology, Ruhr University Bochum, D-44780 Bochum, Germany
    • Corresponding Author InformationCorresponding authors. M. Krüger is to be contacted at Dept. of Cardiovascular Physiology, Ruhr University Bochum, MA 2/146, Universitätsstr. 150, D-44780 Bochum, Germany. Tel.: +49 234 3229104; fax: +49 234 3214040. W.A. Linke, Dept. of Cardiovascular Physiology, Ruhr University Bochum, MA 3/56, Universitätsstr. 150, D-44780 Bochum, Germany. Tel.: +49 234 3229100; fax: +49 234 3214040.
    • Authors contributed equally to this study.
    • ,
  • Kamila Babicz

      Affiliations

    • Dept. of Cardiovascular Physiology, Ruhr University Bochum, D-44780 Bochum, Germany
    • Physiology and Biophysics Unit, University of Münster, D-48149 Münster, Germany
    • Authors contributed equally to this study.
    • ,
  • Marion von Frieling-Salewsky

      Affiliations

    • Dept. of Cardiovascular Physiology, Ruhr University Bochum, D-44780 Bochum, Germany
    • ,
  • Wolfgang A. Linke

      Affiliations

    • Dept. of Cardiovascular Physiology, Ruhr University Bochum, D-44780 Bochum, Germany
    • Corresponding Author InformationCorresponding authors. M. Krüger is to be contacted at Dept. of Cardiovascular Physiology, Ruhr University Bochum, MA 2/146, Universitätsstr. 150, D-44780 Bochum, Germany. Tel.: +49 234 3229104; fax: +49 234 3214040. W.A. Linke, Dept. of Cardiovascular Physiology, Ruhr University Bochum, MA 3/56, Universitätsstr. 150, D-44780 Bochum, Germany. Tel.: +49 234 3229100; fax: +49 234 3214040.

Received 30 October 2009 ,Revised 4 February 2010 ,Accepted 15 February 2010.

References 

  1. Linke WA. Sense and stretchability: the role of titin and titin-associated proteins in myocardial stress-sensing and mechanical dysfunction. Cardiovasc Res. 2008;77(4):637–648
  2. Freiburg A, Trombitas K, Hell W, Cazorla O, Fougerousse F, Centner T, et al. Series of exon-skipping events in the elastic spring region of titin as the structural basis for myofibrillar elastic diversity. Circ Res. 2000;86:1114–1121
  3. Bang ML, Centner T, Fornoff F, Geach AJ, Gotthardt M, McNabb M, et al. The complete gene sequence of titin, expression of an unusual approximately 700-kDa titin isoform, and its interaction with obscurin identify a novel Z-line to I-band linking system. Circ Res. 2001;89:1065–1072
  4. Krüger M, Linke WA. Titin-based mechanical signalling in normal and failing myocardium. J Mol Cell Cardiol. 2009;46:490–498
  5. Opitz CA, Leake MC, Makarenko I, Benes V, Linke WA. Developmentally regulated switching of titin size alters myofibrillar stiffness in the perinatal heart. Circ Res. 2004;94:967–975
  6. Warren CM, Krzesinski PR, Campbell KS, Moss RL, Greaser ML. Titin isoform changes in rat myocardium during development. Mech Dev. 2004;121:1301–1312
  7. Kruger M, Kohl T, Linke WA. Developmental changes in passive stiffness and myofilament Ca2+ sensitivity due to titin and troponin-I isoform switching are not critically triggered by birth. Am J Physiol Heart Circ Physiol. 2006;291:H496–H506
  8. Neagoe C, Kulke M, del Monte F, Gwathmey JK, de Tombe PP, Hajjar RJ, et al. Titin isoform switch in ischemic human heart disease. Circulation. 2002;106:1333–1341
  9. Nagueh SF, Shah G, Wu Y, Torre-Amione G, King NM, Lahmers S, et al. Altered titin expression, myocardial stiffness, and left ventricular function in patients with dilated cardiomyopathy. Circulation. 2004;110:155–162
  10. Makarenko I, Opitz CA, Leake MC, Neagoe C, Kulke M, Gwathmey JK, et al. Passive stiffness changes caused by upregulation of compliant titin isoforms in human dilated cardiomyopathy hearts. Circ Res. 2004;95:708–716
  11. Wu Y, Peng J, Campbell KB, Labeit S, Granzier H. Hypothyroidism leads to increased collagen-based stiffness and re-expression of large cardiactitin isoforms with high compliance. J Mol Cell Cardiol. 2007;42(1):186–195
  12. Klein I, Ojamaa K. Thyroid hormone and the cardiovascular system. N Engl J Med. 2001;344:501–509
  13. Kruger M, Sachse C, Zimmermann WH, Eschenhagen T, Klede S, Linke WA. Thyroid hormone regulates developmental titin isoform transitions via the phosphatidylinositol-3-kinase/AKT pathway. Circ Res. 2008;102:439–447
  14. Dillmann WH. Cellular action of thyroid hormone on the heart. Thyroid. 2002;12:447–452
  15. Harvey CB, Williams GR. Mechanism of thyroid hormone action. Thyroid. 2002;12:441–446
  16. Warren CM, Krzesinski PR, Greaser ML. Vertical agarose gel electrophoresis and electroblotting of high-molecular-weight proteins. Electrophoresis. 2003;24:1695–1702
  17. Prado LG, Makarenko I, Andresen C, Kruger M, Opitz CA, Linke WA. Isoform diversity of giant proteins in relation to passive and active contractile properties of rabbit skeletal muscles. J Gen Physiol. 2005;126:461–480
  18. Li H, Linke WA, Oberhauser AF, Carrion-Vazquez M, Kerkvliet JG, Lu H, et al. Reverse engineering of the giant muscle protein titin. Nature. 2002;418:998–1002
  19. Machackova J, Barta J, Dhalla NS. Molecular defects in cardiac myofibrillar proteins due to thyroid hormone imbalance and diabetes. Can J Physiol Pharmacol. 2005;83:1071–1091
  20. Hsu KL, Tsai CH, Chiang FT, Lo HM, Tseng D, Wang SM, et al. Myocardial mechanics and titin in experimental insulin-resistant rats. Jpn Heart J. 1997;38(5):717–728
  21. Belke DD, Betuing S, Tuttle MJ, Graveleau C, Young ME, Pham M, et al. Insulin signaling coordinately regulates cardiac size, metabolism, and contractile protein isoform expression. J Clin Invest. 2002;109(5):629–639
  22. Aldoretta PW, Carver TD, Hay WW. Maturation of glucose-stimulated insulin secretion in fetal sheep. Biol Neonate. 1998;73(6):375–386
  23. Ma MX, Blenis J. Molecular mechanisms of mTOR-mediated translational control. Nat Rev. 2009;10:307–318
  24. Dennis PB, Fumagalli S, Thomas G. Target of rapamycin (TOR): balancing the opposing forces of protein synthesis and degradation. Curr Opin Genet Dev. 1999;9:49–54
  25. Litwin SE, Raya RE, Anderson PG, Daugherty S, Goldman S. Abnormal cardiac function in the streptozotocin-diabetic rat. Changes in active and passive properties of the left ventricle. J Clin Invest. 1990;86:481–488
  26. Akula A, Kota MK, Gopisetty SG, Chitrapu RV, Kalagara M, Kalagara S, et al. Biochemical, histological and echocardiographic changes during experimental cardiomyopathy in STZ-induced diabetic rats. Pharmacol Res. 2003;48(5):429–435
  27. Dhalla NS, Liu X, Panagia V, Takeda N. Subcellular remodeling and heart dysfunction in chronic diabetes. Cardiovasc Res. 1998;40:239–247
  28. Krüger M, Linke WA. Protein kinase-A phosphorylates titin in human heart muscle and reduces myofibrillar passive tension. J Muscle Res Cell Motil. 2006;27:435–444
  29. Krüger M, Kötter S, Grützner A, Lang P, Andresen C, Butt-Dörje E, et al. Protein kinase G modulates human myocardial passive stiffness by phosphorylation of the titin springs. Circ Res. 2009;104:87–94
  30. Borbely A, van der Velden J, Papp Z, Bronzwaer JG, Edes I, Stienen GJ, et al. Cardiomyocyte stiffness in diastolic heart failure. Circulation. 2005;111:774–781
  31. Hidalgo C, Hudson B, Bogomolovas J, Zhu Y, Anderson B, Greaser M, et al. PKC phosphorylation of titin's PEVK element: a novel and conserved pathway for modulating myocardial stiffness. Circ Res. 2009;105(7):631–638
  32. Grützner A, Garcia-Manyes S, Kötter S, Badilla CL, Fernandez JM, Linke WA. Modulation of titin-based stiffness by disulfide bonding in the cardiac titin N2-B unique sequence. Biophys J. 2009;97(3):825–834
  33. Zeng G, Nystrom F, Ravichandran LV, Cong LN, Kirby M, Mostowski H, et al. Roles for insulin receptor, PI3-Kinase, and Akt in insulin-signaling pathways related to production of nitric oxide in human vascular endothelial cells. Circulation. 2000;101:1539–1545
  34. Abdallah Y, Gkatzoflia A, Gligorievski D, Kasseckert S, Euler G, Schlüter KD, et al. Insulin protects cardiomyocytes against reoxygenation-induced hypercontracture by a survival pathway targeting SR Ca2± storage. Cardiovasc Res. 2006;70:346–353
  35. Sarbassov DD, Ali SM, Kim DH, Guertin DA, Latek RR, Erdjument-Bromage H, et al. Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton. Curr Biol. 2004;14(14):1296–1302
  36. van Heerebeek L, Hamdani N, Handoko L, Falcao-Pires I, Musters RJ, Kupreishvili K, et al. Diastolic stiffness of the failing diabetic heart. Importance of fibrosis, advanced glycation end products, and myocyte resting tension. Circulation. 2008;117:43–51
  37. Radovits T, Korkmaz S, Loganathan S, Barnucz E, Bömicke T, Arif R, et al. Comparative investigation of the left ventricular pressure–volume relationship in rat models of type 1 and type 2 diabetes mellitus. Am J Physiol. 2009;297:H125–H133

PII: S0022-2828(10)00047-7

doi: 10.1016/j.yjmcc.2010.02.012

Journal of Molecular and Cellular Cardiology
Volume 48, Issue 5 , Pages 910-916 , May 2010

Article Tools

* Image Usage & Resolution